ClinicalTrials.gg
Sign In

Solitary Pulmonary Nodule clinical trials

The registry lists 93 studies for Solitary Pulmonary Nodule across more than 10 countries. 20 are recruiting or about to start. 69 of them are mainly about Solitary Pulmonary Nodule (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-14.

Get an email when these change. Save the Solitary Pulmonary Nodule studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
38
Status unknown
19
Recruiting
12
Not yet recruiting
8
Active, not recruiting
7
Terminated
5

Phase

Phase 2
4
Phase 3
3
Early Phase 1
2
Phase 1
2
Phase 4
1

Where

United States
27
China
26
United Kingdom
4
Netherlands
3
Canada
3
Taiwan
3

Who runs them

Boston Scientific Corporation (2) · Peking University People's Hospital (2) · Chinese Alliance Against Lung Cancer (2) · Beijing Aerospace General Hospital (2) · Erasme University Hospital (2) · Intuitive Surgical (2) · Wen-zhao ZHONG (2) · Seoul National University Hospital (2)

What is being tested here

Drugs under test in Solitary Pulmonary Nodule studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Indocyanine Green002
Florilglutamic acid f-18001
Methylene Blue001
Belinostat001

Coming up

1phase 3 study under way
6studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Who these studies take

Of the 12 Solitary Pulmonary Nodule studies recruiting now, 6 (50%) set no upper age limit and 1 (8%) stop at 75 or younger. 2 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (17%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
102 (17%)2 (17%)
188 (67%)8 (67%)
309 (75%)9 (75%)
4012 (100%)12 (100%)
5012 (100%)12 (100%)
6512 (100%)12 (100%)
7511 (92%)11 (92%)
859 (75%)9 (75%)

Across all 93 studies, recruiting or not: 10% stop at 75 or younger and 2% at 65; 9% take children; 0% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Solitary Pulmonary Nodule studies take

Of 24 interventional studies with no phase under Solitary Pulmonary Nodule, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo9–43 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 93. Browse all 93 → or search them.